Director/PDMR Shareholding

RNS Number : 6005L

Dechra Pharmaceuticals PLC

13 September 2021

 

13 September 2021

Dechra Pharmaceuticals PLC

(the Company or Dechra)

Notification of Transactions by Person Discharging Managerial Responsibilities

On 10 September 2021, Dechra Pharmaceuticals PLC was notified by a Director of the Company and Person Discharging Managerial Responsibilities that he had completed the sale of part of his beneficial interest in Dechra.

Tony Griffin, Executive Director, has sold 17,500 ordinary shares in the Company   to satisfy long term personal financial planning considerations and widen his investment portfolio. Following this transaction, Tony Griffin will continue to retain a beneficial holding of 28,150 ordinary shares which represents 0.026% of the current issued share capital in the Company.

The Notification of Dealing Form set out below is provided in accordance with the UK Market Abuse Regulation.

Notification of Dealing Form:

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Tony Griffin
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Sale of Shares
c)	Price(s) and volumes(s)	Price(s) £50.01492	Volume(s) 17,500
d)	Aggregated information -Aggregate volume - Price - Total	17,500 £50.01492 £875,261.10
e)	Date of the transaction	10 September 2021
f)	Place of the transaction	London Stock Exchange

Enquiries:
Dechra Pharmaceuticals PLC
Ian Page, Chief Executive Officer	Office:  [phone]
Paul Sandland, Chief Financial Officer e-mail: [e-mail]	Office:  [phone]
TooleyStreet Communications Ltd
Fiona Tooley, Director e-mail: [e-mail]	Office:  [phone] Mobile: [phone]

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com  

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHBDGDCBUBDGBX